EANS-Adhoc: LifeWatch AG / hires top Healthcare Executive to lead Sales

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Company Information

16.09.2010

Stephen J. Zielinski appointed Senior Vice President of Sales of
LifeWatch Corp.

Neuhausen am Rheinfall/ Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) announced today the appointment of Stephen J.
Zielinski as Senior Vice President of Sales of LifeWatch Corp.,
effective September 20, 2010. Brent Atwood, former Chief Sales
Officer of LifeWatch Services, Inc., will pursue opportunities
outside the company.

Mr. Stephen Zielinski brings to LifeWatch over 20 years of sales and
sales management experience with leading firms in the cardiology and
medical device industries. Mr. Zielinski has specialized in building
and growing sales organizations. His past experience includes VP of
Sales for Angiotech´s Interventional & Surgical products, where he
managed a dozen regional managers and 120 sales representatives. Mr.
Zielinski spent thirteen years with Boston Scientific (Minnesota,
USA) where he was most recently the Director of Sales for the
Peripheral & Vascular Division and the Cardiovascular Division. In
addition, Mr Zielinski led the new product launch of Boston
Scientific´s highly successful Taxus stent line. During his tenure at
Boston Scientific, Mr. Zielinski also led the development and
operation of a sales training division of 38 specialists and trainers
and was responsible for the integration of sales force automation
tools to over 300 sales representatives. Mr. Zielinski previously
held senior sales management positions at various other firms such as
CoAxia, Inc. (Minnesota, USA), an early stage company focusing on
products for ischemic stroke. Mr. Zielinski holds a Bachelor of
Science degree in Business Management from Purdue University.

"We are very excited that Steve is joining LifeWatch as we expand our
advanced wireless healthcare services to other remote patient
monitoring markets," stated Brent Cohen, CEO of LifeWatch AG, the
parent company of LifeWatch Corp. "His deep, cardiac-related
experience and proven management skills will be invaluable assets as
we continue to expand our presence in the cardiac monitoring market
and as we enter new service industries such as home sleep testing."

About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am
Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is
the leading healthcare technology and solution company, specializing
in advanced telemedicine systems and wireless remote patient
monitoring services. LifeWatch services cater to individuals,
ranging from high-risk and chronically ill patients, to
consumers of health and wellness products. LifeWatch has
subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider. LifeWatch has also introduced a new
program for Home Sleep Testing of Obstructive Sleep Apnea (OSA)
patients under the brand name NiteWatch. For additional
information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results
of operations and financial position, business strategy and plans
and objectives for future operations, are forward- looking
statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar
expressions are intended to identify forward-looking statements.
LifeWatch AG has based these forward- looking statements largely
on current expectations and projections about future events and
financial trends that it believes may affect the financial
condition, results of operations, business strategy, short term and
long term business operations and objectives, and financial needs.
These forward-looking statements are subject to a number of risks,
uncertainties and assumptions. In light of these risks,
uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could
differ materially and adversely from those anticipated or implied
in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at
the time of the issue of this press release. LifeWatch AG does
not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new
information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS
OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED
STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF
SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED
STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS
SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE
UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO
BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS
THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS
APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER
AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

For further information please contact:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch

Tel +1 847 813 4299 | Fax +1 847 813 24 48 | E-mail wkim@lifewatch.com

Sensus Investor & Public Relations, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard